The present application describes modulators of MCP-1 of formula (I): ##STR00001## or pharmaceutically acceptable salt forms thereof, useful for the prevention of rheumatoid arthritis, multiple sclerosis, atherosclerosis and asthma.

 
Web www.patentalert.com

< Antibodies to peptide fragments having cell death-inhibitory activity

> Characterization of GRP94-ligand interactions and purification, screening, and therapeutic methods relating thereto

> Materials and methods relating to the induction of apoptosis in target cells
~ 00536